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ABSTRACT
Objective: The objective of this study was to determine the utility of tissue Doppler imaging (TDI) in detecting early right ventricle (RV) myocardial 
dysfunction, given its prognostic implications in patients with chronic obstructive pulmonary disease (COPD).
Methods: A prospective case-control study was carried out involving 36 COPD patients in an acute exacerbated state as cases and 34 healthy subjects 
serving as controls. Each subject underwent a baseline echocardiography using various methods ranging from m-mode and two-dimensional measures 
for analyzing RV geometry to strain and strain rate using TDI to measure RV deformation. The cases underwent a subsequent echocardiogram 1 month 
later once the respiratory symptoms subsided.
Results: A significant difference was observed in RV tissue annular velocities (E’, A’, S) between cases and the controls at baseline. However, no 
significant increase was observed in tissue annular velocities among cases during remission states from baseline. Peak systolic strain in COPD group 
was significantly reduced in comparison to controls, but not significantly increased during remission when compared to baseline in cases. Forced 
expiratory volume in 1 second/vital capacity did not bear any significant correlation with RV strain. TEI index had a negative linear correlation with 
peak systolic strain of RV, which was statistically significant.
Conclusion: TDI parameters revealed that RV dysfunction remains unaltered even in remission state of COPD despite pulmonary arterial pressure 
normalizing. In light of it bearing a negative prognosis in COPD, RV dysfunction merits assessment in COPD patients, both in acute exacerbations as 
well as in remission.
Keywords: Strain rate, Tissue annular velocity, Doppler, Right ventricle geometry, Case-Control.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is associated with 
considerable morbidity and is predicted to become the third leading 
cause of death worldwide by 2020 [1,2]. Early in the course of the disease 
respiratory symptoms predominate, while later systemic complications 
include osteoporosis, loss of fat-free mass [3], and cardiovascular 
disease [4,5]. Cardiovascular complications in patients with COPD 
include cor pulmonale [6], a 2-3 fold excess cardiovascular event risk 
even after allowing for confounders such as smoking [7] and a greater 
than fourfold excess risk of chronic heart failure [8]. Arterial stiffness, an 
independent predictor of cardiovascular outcome [9,10] was increased 
in patients with COPD, free of cardiovascular disease, suggesting 
acceleration of age-dependent stiffening [11]. It was found that even 
in mild severity airways obstruction, stiffening develops in early lung 
disease in parallel with asymptomatic changes in pulmonary arterial 
(PA) pressure and right ventricular (RV) function [12,13]. Long-term 
effects of increased arterial stiffness in COPD are unknown but might 
include cardiac adaptations similar to those in normal aging [14-17], 
systemic hypertension [18], and diastolic heart failure [19]. Such 
changes in cardiac structure and function may underlie the increased 
risk of cardiovascular disease in COPD.
COPD is often associated with changes of the structure and the function 
of the heart. Although functional abnormalities of the RV have been 
well described in COPD patients with severe hypoxemia, little is known 
about these changes in patients with normoxia and mild hypoxemia. 
The evaluation of RV function is clinically useful in patients with COPD 
because the presence of RV failure has prognostic implications [20,21]. 
All invasive and noninvasive techniques evaluating RV performance 
have important limitations due to the complex geometry of the RV. The 
introduction of Doppler measurement of myocardial wall velocities 
(tissue Doppler imaging (TDI) and the recent development of strain 
rate imaging (SRI) technique have made a more adequate assessment 
of global and regional systolic and diastolic RV function possible. Hence, 
the aim of this study is to detect early RV myocardial dysfunction in 
patients with COPD using TDI, and the main objectives are to compare 
the TDI parameters such as strain, SR, tissue annular velocities between 
COPD patients who are in exacerbation state and healthy individuals, 
RV deformation parameters in patients at exacerbation event and after 
the remission state, the TDI-derived parameters in COPD patients 
who are in remission state and healthy individuals and to assess the 
correlation among tissue Doppler parameters and pulmonary function 
tests in COPD patients.
METHODS
A prospective, case-control study, compliant with the Declaration of 
Helsinki, was performed in the Department of Cardiology, Kasturba 
Hospital, Manipal. Institutional Ethical Clearance was obtained. 
Subjects were recruited after obtaining a written informed consent. 
Patients with COPD in an acute exacerbation state were included as 
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cases. Further, subjects with clinical evidence of cor pulmonale, clinical 
or electrocardiographic evidence of systemic hypertension, myocardial 
ischemia, valvular diseases and any irregular cardiovascular rhythm 
disorders were excluded from the study. Healthy subjects appearing for 
health check-up, who had normal cardiac findings served as controls 
and were drawn by frequency matching technique. Echocardiographic 
examination was performed before medical therapy was initiated. 
Subsequently, a comparison echocardiographic examination was 
performed at least 1 month after the symptoms were controlled. The 
diagnosis of COPD was made on the basis of a review of patient’s 
history, physical examination, chest radiographs, and standard 
pulmonary function tests; according to the criteria established by 
the global initiative for chronic obstructive lung disease [22]. Acute 
exacerbation of COPD was defined as worsening dyspnea, increase in 
sputum purulence and increased sputum volume in accordance with 
ACCP acute exacerbation guidelines [23].
Echocardiography
Individuals were subjected to complete clinical examination and 
transthoracic echocardiography using Vivid 7 – echocardiography 
system with a 2.5 MHz transducer. Echocardiographic parameters were 
evaluated after pulmonary function test was performed, i.e., forced 
expiratory volume in 1 second/vital capacity (FEV1/VC).
Measurements of right heart chambers were done according to 
established criteria [24,25]. RV end-diastolic (ED) and end-systolic (ES) 
areas were assessed by manual planimetry, and then RV fractional area 
change (RVFA) was derived using the formula [20].
Using m-mode technique RVED dimension (EDD), isovolumic 
contraction IVC diameter, and left ventricular (LV) internal dimensions 
were obtained. Tricuspid annular plane systolic excursion (TAPSE) was 
measured in A4CH view. Trans tricuspid valve Doppler flow velocities, 
i.e., peak early and late diastolic velocities were recorded from A4CH 
view, Deceleration time, isovolumic relaxation time (IVRT), IVC time 
(IVCT), and ejection time were measured with the additional recording 
of transpulmonary valve Doppler flow velocity. Pulmonary artery 
systolic pressure was estimated by continuous wave Doppler as 4 times 
square of peak regurgitation velocity plus assumed right atrial pressure 
of 10 mmHg (fixed value method) [20]. For the analysis of global RV 
function, Doppler parameters were used to derive the TEI index, 
i.e., (IVCT+IVRT)/ET.
TDI
Recordings were stored digitally as two-dimensional (2D) cineloops 
and were transferred to an optical disk medium workstation for off-
line analysis. The images showing the tissue motion velocity were 
superimposed on the 2D echocardiographic images for real-time color 
display. TDI annular velocities during systole, early relaxation (Ea), 
and atrial systole (Aa) were possessed from RV free wall (FW) and 
interventricular septum (IVS) at basal site in the A4CH view. The strain 
(change in length per unit length) in each segment is defined [26] as 
the relative magnitude of segmental deformation. From tissue Doppler 
data, SR was estimated by calculating the velocity gradient. The time 
integral of incremental SR yields logarithmic strain: E=log (L/L0). In 
this study, the logarithmic strain was converted to Lagrangian strain: 
E=(L-L0)/L0.
SR is determined during systole (S), early diastole (E), and late 
diastole (A). Systolic strain was measured from the same wall site in 
the same views. TDI wall velocities at the tricuspid annulus level during 
systole, early relaxation and atrial systole were also obtained.
Statistical analysis
Sample size was calculated to be 29 cases and 29 controls and statistical 
analysis was done. Data were entered in excel sheet and analyzed using 
appropriate statistical methods (independent t-test for intergroup 
comparison and paired t-test for intragroup comparison). A p<0.05 was 
considered as statistically significant.
RESULTS
This study included 36 subjects in COPD with acute exacerbation 
group and 34 controls. The mean age in COPD group and controls were 
63±9.9 and 59±10, respectively. Cases, in our study, included 16 females 
and 20 males (Table 1). Among the subjects with COPD 5 (13.9%) were 
smokers and 3(8.3%) were alcoholic.
About 36 subjects with acute exacerbation of COPD underwent 
pulmonary function test as diagnostic sequence. The mean value of 
FEV1/VC) was found to be 0.62±0.11 resembling obstructive in its 
nature. After a month of acute exacerbation (A/E), event subjects were 
enrolled for repeat PFT after confirming their remission state based 
on their symptoms. The test showed a significant increase in the value 
of FEV1/VC among subjects in remission state after an exacerbation 
event, i.e., 0.62±0.11 vs. 0.67±0.12 (p=0.001) (Fig. 1).
Echocardiography was performed on COPD patients in their exacerbated 
state which included various methods ranging from m-mode and 2D 
measures for analyzing RV geometry to strain and SR using TDI to 
measure RV deformation. To ensure the subclinical as well as clinically 
significant changes that occur in COPD subjects, the echocardiographic 
parameters were compared with the healthy individuals who were 
matched with respect to age and gender.
Thus, echocardiographic parameters were compared between three 
groups which included patients with acute exacerbation of COPD, same 
subjects at remission state and the control group. The parameters 
among the patients with acute exacerbation of COPD state and in the 
remission state were analyzed using paired t-test ensuring that the 
continuous variable was normally distributed. The variables were 
compared with the controls using independent t-test.
LV m-mode parameters
LV m-mode echocardiography showed statistically significant 
difference in IVS dimension, LVEDD, ESD between COPD patients and 
controls with p=0.007, 0.03, and 0.002, respectively. LVEF as measured 
by Simpson’s method was significantly reduced in patients with COPD 
when compared with controls (p=0.02) (Table 2).
RV geometry
RV geometry assessment was made by M-mode echocardiography, 
2D RV dimension to obtain RVFW thickness, RVED dimension, TAPSE, 
RVFA change. According to the current study the RVFW thickness, RV 
Table 1: Cases and controls
Group Gender Total
Male Female
Controls 11 23 34
COPD subjects 20 16 36
Total 31 39 70
COPD: Chronic obstructive pulmonary disease
Fig. 1: Cases and control percentage distribution
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internal dimensions were found to be increased in COPD patients when 
compared with controls. There was statistically significant difference 
noted in the value of TAPSE between COPD patients and controls 
(Table 3). As far as RV geometry is considered, there was no significant 
change in the values of RV internal dimensions and FW thickness 
were noted in A/E COPD patients during the follow-up period in the 
remission state; however, the IVC dimension was significantly higher in 
COPD group and was found to be reduced in remission state from A/E 
event.
Doppler echocardiography
Findings showed significantly elevated RV systolic pressure in COPD 
patients when compared with controls; however, this was found to be 
reduced after remission state of A/E of COPD (p<0.001). Tricuspid late 
diastolic A wave, IVRT, TEI index values were significantly increased in 
COPD patients whereas E/A ratio, deceleration time were significantly 
reduced in COPD with A/E group, whereas deceleration time was found 
to be improved after remission state (p=0.01) (Table 4).
TDI
RV tissue annular velocities (E’, A’, S) were found to be significantly 
different between COPD subjects and the controls; however, RV E’ and 
S values were significantly reduced in COPD group with no significant 
increase in its value after the remission state; suggesting, the subtle 
decline in RV function parameters remain unchanged even in the 
remission state after an A/E event in COPD patients. E’ and A’ of IVS 
were also reduced in COPD patients, whereas S-Systolic annular velocity 
did not show significant difference among three groups. Reduction in 
diastolic component of tissue annular velocity of IVS, i.e., E’ may be due 
to RV strain which is resulting in impaired relaxation of IVS (Table 5).
RV deformation
Imaging revealed a significant reduction in peak systolic strain in patients 
with A/E of COPD when compared with controls, and was slightly 
increased at the remission state on follow-up from the baseline, but found 
to be statistically insignificant. Peak systolic strain of IVS was reduced 
significantly among A/E group in comparison with controls, and the 
same in follow-up also showed increased value, suggesting improved IVS 
strain in remission state after an A/E event in COPD patients. Systolic SR 
(SSR) of both RVFW and the IVS were significantly reduced in COPD with 
A/E patients with no significant change in its value on follow-up noted. 
Early diastolic SR (ESR) in RVFW was lower in COPD group, whereas ESR 
of IVS did not show a significant difference between each group (Table 6).
Correlation between FEV1/VC and the tissue Doppler parameters was 
analyzed using Pearson correlation test depending on the normality 
Table 2: ECHO parameters
Echo parameters Controls COPD with A/E state Remission state after A/E event
IVSD (mm) 8.35±1.12 9.28±1.59 9.19±1.33*
IVSS (mm) 13.09±1.42 13.53±1.92 13.83±1.5
LVEDD (mm) 42.94±7.87 46.42±5.49 46.36±5.53*
LVESD (mm) 26.21±3.86 28.97±4.48 29.08±3.67*
PWD (mm) 9.12±3.9 8.33±1.21 8.06±0.9
PWS (mm) 12.53±2.7 12.31±1.43 12.36±1.07
EF (%) 70.15±3.47 67.86±4.87* 67.89±3.7*
FS (%) 39.53±2.85 37.89±3.74* 37.83±2.48*
HR (bpm) 81.53±17.99 86.89±14.93 79.78±11.11§
IVSD: Inter ventricular septum in diastole, IVSS: Inter ventricular septum in systole, LVEDD: Left ventricular end diastolic dimension, LVESD: Left ventricular end systolic 
dimension, PWD: Posterior wall in diastole, PWS: Posterior wall in systole, EF: Ejection fraction, FS: Fractional shortening, HR: Heart rate, COPD: Chronic obstructive 
pulmonary disease, *p<0.05 vs. controls, §p<0.05 vs. A/E of COPD group
Table 3: RV geometry
Echo parameters Controls COPD with A/E state Remission state after A/E event
RVFWT (mm) 3.95±0.65 5.83±0.87* 5.91±1.02*
RVEDD (mm) 21.76±3.2 23.28±4.19 22.64±3.55
RVED SAX (mm) 25.53±4 26.14±4.91 28.03±7.31
RVED LAX (mm) 52.5±7.46 52.83±7.24 51.83±9.26
RVES SAX (mm) 20.32±2.84 23.00±5.86* 23.97±6.6*
RVES LAX (mm) 37.85±5.01 40.11±6.28* 41.11±0.76*
RVFA (%) 46.04±7.16 38.48±9.38* 38.77±8.3*
TAPSE (mm) 21.88±2.38 20.25±2.5* 20.19±2.14*
IVC MAX (mm) 12.44±1.44 13.61±3.6 12.50±3.1
IVC MIN (mm) 5.44±89 7.03±2.5* 6.22±2.21*§
RVFWT: Right ventricular free wall thickness, RVEDD: Right ventricular end diastolic dimension, SAX: Short axis, LAX: Long axis, RVED: Right ventricular dimension 
in end diastole, RVES: Right ventricular dimension in end systole, RVFA: Right ventricular fractional area change, TAPSE: Tricuspid annular plane systolic excursion, 
IVC: Inferior vena cava, MAX: Maximum, MIN: Minimum, COPD: Chronic obstructive pulmonary disease, RV: Right ventricle, *p<0.05 vs. controls, §p<0.05 vs. A/E of COPD 
group
Table 4: Doppler echocardiography
Echo parameters Controls COPD with A/E state Remission state after A/E event
RVSP (mmHg) 22.79±3.51 39.25±10.58* 29±5.3*§
TV-E (cm/s) 62.68±13.83 60.25±15.71 59.38±15.03
TV-A (cm/s) 49.74±15.3 61.64±15.03* 58.56±18.27*
TV-E/A 1.31±0.24 1.00±0.3* 1.05±0.31*
IVRT (ms) 59.32±10.43 80.22±23.52* 83.06±18.34*
DT (ms) 188.94±26.22 165.33±49.8* 180.64±40.9§
TEI index 0.43±0.07 0.59±0.11* 0.60±0.10*
RVSP: Right ventricular systolic pressure, TV-E: Tricuspid valve early diastolic velocity, TV-A: TV late diastolic velocity, IVRT: Iso-volemic relaxation time, 
DT: Deceleration time, COPD: Chronic obstructive pulmonary disease, *p<0.05 vs. controls, §p<0.05 vs. A/E of COPD group
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distribution of the given variable. The RV strain as measured by tissue 
Doppler technique showed a positive correlation with FEV1/VC ratio 
though was not statistically significant (Table 7 and Fig. 2).
SSR of RV also did not show significant linear correlation with the 
values of FEV1/VC (Table 8 and Fig. 3).
The measure of global RV function, TEI index was well correlated with 
the value of peak systolic strain of RV and was statistically significant 
with negative linear correlation (Table 9 and Fig. 4).
However, the FEV1/VC did not show significant linear correlation with 
systolic tissue annular velocity of RV (Fig. 5).
DISCUSSION
This study shows that, in COPD patients, tissue Doppler parameters 
can detect RV dysfunction that is complementary to conventional 
echocardiographic indices and they correlate with severity of pulmonary 
disease. This study showed a significant increase in RV thickness and 
the chamber dimensions in patients with COPD when compared to 
controls. RV hypertrophy and dilatation that occurs in COPD patients is 
a beneficial adaptation allowing the ventricle to cope with an increased 
afterload and maintain a normal cardiac output. Progressive RV 
dysfunction is associated with limited peripheral oxygen delivery and 
exercise capacity and has an important bearing on prognosis that is 
independent of other factors, such as severity of airflow obstruction, and 
reflects the interrelationship with deranged pulmonary hemodynamics.
Tricuspid late diastolic A wave, IVRT, TEI index values were significantly 
increased in COPD patients whereas E/A ratio, deceleration time were 
significantly reduced in COPD with A/E group suggesting the presence 
of RV diastolic dysfunction in the study group. Tissue annular velocity 
showed significant reduction in tissue annular motion including RVED and 
RVES velocities as well as early diastolic annular velocity of IVS. This shows 
underlying impairment in RV diastolic as well as systolic function in COPD 
patients. Similar findings were revealed in the study of Vitarelli et al. [27].
RV deformation by TDI
An advantage of using TDI to assess RV function is that measurement is 
independent of geometric assumptions and endocardial border tracing. 
However, one limitation of TDI is that it does not distinguish between 
active and passive wall motion, and this has led to the development of 
the TDI-derived modalities of strain and SR that measure the rate of 
regional myocardial deformation.
This study describes the characteristics of ultrasound-based regional 
deformation indices in patients with acute exacerbation of COPD and 
Table 5: Tissue Doppler imaging
Echo parameters Controls COPD with A/E state Remission state after A/E event
RVE (m/s) 0.13±0.03 0.11±0.02* 0.11±0.03*
RVA (m/s) 0.15±0.05 0.20±0.05* 0.18±0.04*§
RVS (m/s) 0.18±0.02 0.14±0.03* 0.15±0.04*
IVSE (m/s) 0.11±0.02 0.08±0.02* 0.08±0.02*
IVSA (m/s) 0.09±0.02 0.10±0.02* 0.10±0.02*
IVSS (m/s) 0.09±0.01 0.08±0.01 0.08±0.02
RV: Right ventricle, IVS: Inter ventricular septum, E: Early diastolic tissue annular velocity, A: Late diastolic tissue annular velocity, S: Systolic annular velocity, 
COPD: Chronic obstructive pulmonary disease, *p<0.05 vs. controls, §p<0.05 vs. A/E of COPD group
Table 6: RV deformation imaging
Echo parameters Controls COPD with A/E state Remission state after A/E event
RVSI (%) −31.16±3.74 −24.96±4.8* −26.01±1.06*
RV SSR (/s) −2.8±0.64 −1.85±0.46* −1.81±0.58*
RV ESR (/s) 2.54±0.64 1.83±0.52* 2.07±1.5*
RV LSR (/s) 2.41±0.76 2.34±0.67 2.24±0.66
IVS SI (%) −24.62±1.78 −14.80±1.97* −21.01±3.65*§
IVS SSR (/s) −1.57±0.26 −1.29±0.36* −1.36±0.32*
IVS ESR (/s) 1.7±0.52 1.55±0.5 1.55±0.44
IVS LSR (/s) 1.81±0.43 1.63±0.48 1.77±0.59
RV: Right ventricle, IVS: Inter ventricular septum, SI: Systolic strain imaging, SSR: Systolic strain rate, ESR: Early diastolic strain rate, LSR: Late diastolic strain rate, 
COPD: Chronic obstructive pulmonary disease, *p<0.05 vs. controls, §p<0.05 vs. A/E of COPD group
Fig. 2: The right ventricular strain as measured by tissue 
Doppler technique, FEV1/VC_B: Forced expiratory volume in 
1 second/vital capacity at baseline, SI: Strain imaging
Table 7: RV strain as measured by tissue Doppler technique
RV strain FEV1_VC_B SI_RV_AVG_B
FEV1_VC_B









FEV1/VC_B: Forced expiratory volume in one second per vital capacity at 
baseline, SI: Strain imaging, RV: Right ventricle
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Fig. 3: Systolic strain rate of right ventricle, FEV1/VC_B: Forced 
expiratory volume in 1 second/vital capacity at baseline, 
SSR: Systolic strain rate, RV: Right ventricle
Fig. 4: Right ventricle global function measure, TEI B: Tei index of 
RV at baseline, SI: strain imaging, RV: Right ventricle
their correlation with pulmonary function tests. In the patients of the 
current study, reduced regional long-axis shortening was observed in 
all segments of the RVFW. Although the myocardial deformation rate 
and TEI index are two different measurements, this study shows a 
significant correlation between the peak systolic strain and the RV TEI 
index. Furthermore, in contrast to other ultrasound-based methods of 
quantifying global RV function, such as the TEI index, SRI potentially 
allows the quantification of longitudinally systolic and diastolic function 
for each segment of the RV.
The non-homogeneity in longitudinal RV function observed in the 
patients of the current study is presumably a result of the complex 
anatomy of the RV that is comprised three morphologically distinct 
units: A smooth inlet portion, a tubular infundibulum, and a more 
trabeculated apical portion. As a result of their different muscular 
arrangements, each could respond differently to both changes in 
preload and afterload, and fiber stretch as a result of dilatation. 
When the overall RV function is taken into account, the inlet area 
of the RV chamber has a greater contribution compared with the 
trabecular region and the infundibulum. This may explain the 
nonhomogeneous decrease in systolic deformation that occurs 
in COPD patients during times of worsening hypoxia, and hence 
increased afterload stress.
This study demonstrates the utility of SRI parameters for the 
evaluation of RV function in COPD patients. The new echo 
technologies show impairment of RV function that is related to 
pulmonary hypertension and severity of pulmonary disease and are 
more sensitive than conventional echocardiographic parameters. 
SRI indices could provide clinically relevant information on regional 
changes in RV function in chronic pulmonary disease and contribute 
toward an understanding of how the differing structural components 
of the RV deteriorate after increasing afterload, and how they recover 
after appropriate therapy.
Our findings of diastolic dysfunction in patients with COPD, indicated 
by an increased IVRT and E/Ea, are supported by two recent 
studies [27,28].
Impaired RV systolic function, and in particular, reduced contractility 
as indicated by a lower FW strain, SR was present in the patients 
including those with even post exacerbation event at the remission 
state, when compared with controls. None of our patients had 
clinical evidence of cor pulmonale and estimation of PA pressure 
using the tricuspid regurgitant (TR) jet did not separate patient at 
remission state and control groups; however, changes in surrogate 
indices of PA hypertension, including RVFW myocardial relaxation 
time, TEI index, indicated RV functional changes consistent with a 
degree of increased pulmonary vascular resistance and increased 
afterload in patients with both mild and severe lung disease. This 
confirms the findings of RV dysfunction without clinical evidence 
of cor pulmonale in patients with COPD where such features were 
mainly associated with pressures >35 mmHg, though, similar to our 
study, systolic strain and SR reductions were present in patients 
with pressures <35 mmHg [12].
RV function at remission state
This study showed a significant decline in tissue Doppler parameters 
including annular velocity, strain, and SR variables at remission state 
from A/E of COPD event when compared with controls even when 
PA pressure seem to be normal as assessed by TR jet. This finding is 
supported by the study conducted by Hilde et al. [29] where they found 
Table 8: Systolic strain of RV
RV strain FEV1_VC_B SSR_RV_AVG_B
FEV1_VC_B




Pearson correlation 0.097 1
Significant (one-tailed) 0.286
n 36 36
FEV1/VC_B: Forced expiratory volume in one second per vital capacity at 
baseline, SSR: Systolic strain rate, RV: Right ventricle
Table 9: RV global function measure
RV strain TEI_B SI_RV_AVG_B
FEV1_VC_B




Pearson correlation −0.533 1
Significant (one-tailed) 0.000
n 70 70
TEI_B: Tei index of RV at baseline, SI: Strain imaging, RV: Right ventricle
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Fig. 5: Right ventricular global function measure, FEV1/VC_B: 
Forced expiratory volume in 1 second/vital capacity at baseline, 
RVS: Right ventricular systolic tissue annular velocity
that the COPD patients with relatively normal PA pressure possessed 
subclinical RV dysfunction. Thus, the study reveals, permanent changes 
that result due to acute exacerbation event remain unaltered in the 
remission state even when PA pressure drops to a normal range. In a 
study performed by Vitarelli et al. concluded that in COPD patients, 
SRI parameters can determine RV dysfunction that is complementary 
to conventional echocardiographic indices and is correlated with 
pulmonary hypertension and respiratory function tests [12], which can 




by tissue Doppler parameters such as annular velocities, strain and 
SR even when PA pressure falls to normal range
•	 Because	RV	 dysfunction	 has	 a	 negative	 impact	 on	 prognosis,	
assessment of RV function is very important in patients with A/E of 
COPD as well as at remission state
•	 Noninvasive	evaluation	of	RV	 longitudinal	 function	such	as	strain	
and SR by TDI has gained importance because it is easy to obtain, 
quantitative and reproducible.
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